Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
09/2003
09/18/2003US20030176653 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
09/18/2003US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
09/18/2003US20030176648 Ion channel
09/18/2003US20030176392 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV")
09/18/2003US20030176389 Administering to a subject suffering from gastrointestinal inflammation a formulation comprising an immunomodulatory nucleic acid to the subject, the immunomodulatory nucleic acid comprising the sequence 5'-CpG-3'
09/18/2003US20030176388 Fatty acid synthase mRNA binding protein
09/18/2003US20030176387 Regulation of human pyroglutamyl peptidase-like enzyme
09/18/2003US20030176386 Introducing a locus specific targeting fragment into the genome of a cell through homologous recombination by inhibiting endogenous mismatch repair of cell; introducing a locus specific targeting fragment into cell
09/18/2003US20030176381 Hyaluronic acid in the treatment of cancer
09/18/2003US20030176379 Useful in the administration of a drug, therapy
09/18/2003US20030176378 Vaccines and gene therapy compositions and methods of making and using the same
09/18/2003US20030176377 DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
09/18/2003US20030176376 Methods and compositions for treating a cell-proliferative disorder using CRE decoy oligomers, BCL-2 antisense oligomers, and hybrid oligomers thereof
09/18/2003US20030176375 Method of treating anemia
09/18/2003US20030176372 Anti-virus agent
09/18/2003US20030176371 For therapy of autoimmune disorders, cancer
09/18/2003US20030176350 Method of inhibiting cell proliferation using an anti-oncogene protein
09/18/2003US20030176349 Stable hypoxia inducible factor-1 alpha and method of use
09/18/2003US20030176348 For use as therapeutic agent for a syndrome resembling premature aging, a therapeutic agent for adult diseases or an aging-suppressing agent
09/18/2003US20030176347 Remedies for amyotrophic lateral sclerosis
09/18/2003US20030176346 Using substances that activate the CNTF (ciliary neurotrophic factor) receptor for the preparation of pharmaceutical formulations for therapy of obesity and diseases associated therewith, for example diabetes
09/18/2003US20030176343 Administering to the subject an amount of topors (protein) effective to inhibit the uncontrolled proliferation for therapy
09/18/2003US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent
09/18/2003US20030176336 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
09/18/2003US20030176335 Surfactant peptide nanostructures, and uses thereof
09/18/2003US20030176332 Novel use of cytokine inhibitors
09/18/2003US20030176330 55562 and 21617, novel human proteins and methods of use thereof
09/18/2003US20030175974 Human gene therapy
09/18/2003US20030175973 Targeted recombinant viral vectors
09/18/2003US20030175971 Differentiation and/or proliferation modulating agents and uses therefor
09/18/2003US20030175966 Cationic sugar derivatives for gene transfer
09/18/2003US20030175961 Immortal micorvascular endothelial cells and uses thereof
09/18/2003US20030175934 Controlling cell differentiation, cell proliferation; anticancer agents
09/18/2003US20030175905 Anticholesterol agents; antilipemic agent; antiinflammatory agents; obesity
09/18/2003US20030175898 Isolated nucleic acids; immune response disease
09/18/2003US20030175890 For treatment of auto-immune and immunde disorders and chronic obstructive pulmonary disease; FAIL is an Fc receptor
09/18/2003US20030175881 Nucleic acids encoding (poly) peptides having chips activity
09/18/2003US20030175855 Human sdf-5 protein and compositions
09/18/2003US20030175805 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering
09/18/2003US20030175783 Methods and means for monitoring and modulating gene silencing
09/18/2003US20030175772 Microarray of nuclelotide sequences for use in gene expression inhibition; antisense therapy; antitumor agents
09/18/2003US20030175766 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
09/18/2003US20030175763 Identification of an amplified gene and target for drug intervention
09/18/2003US20030175751 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis
09/18/2003US20030175748 Novel human G-protein coupled receptor, HGPRBMY3, expressed highly in immune- and colon- related tissues
09/18/2003US20030175745 Peptides with growth inhibitory action
09/18/2003US20030175741 PCP-administered (phencyclidine/angel dust) chronic animal models; drug screening
09/18/2003US20030175712 Comprises nucleic acid coding cell division cycle molecule (CDC24); g-protein coupled receptor for treatment and prevention of fungal infections; antitumor agents
09/18/2003US20030175688 Preparing replication competent viral vectors for treating cancer; genetic vaccines; gene therapy; antitumor agents
09/18/2003US20030175681 Inhibition of CMV infection and dissemination
09/18/2003US20030175301 Rotavirus pseudoviral particles and use thereof for vectorizing proteins of nucleic acids
09/18/2003US20030175293 Choline binding proteins for anti-pneumococcal vaccines
09/18/2003US20030175292 Compositions and methods for generating an immune response
09/18/2003US20030175291 Multiple and multivalent DNA vaccines in ovo
09/18/2003US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents
09/18/2003US20030175266 Peptides having amino acid sequences or fragments from human proteins, used as antitumor, anticarcinogenic and/or antiproliferative agents
09/18/2003US20030175260 Novel DNA and a process for its use
09/18/2003US20030175257 Cartilage regeneration using chondrocyte and TGF-beta
09/18/2003US20030175254 Separating population based on density and size of cells via elution then cetrifugation; for secretion of neuroendocrine hormones
09/18/2003US20030175252 Therapeutic compounds for ovarian cancer
09/18/2003US20030175245 Replication deficient adenoviral TNF vector
09/18/2003US20030175244 Capsid-modified recombinant adenovirus and methods of use
09/18/2003US20030175243 Blocking receptor binding; gene therapy; gastrin releasing peptide
09/18/2003US20030175242 Cell therapy system
09/18/2003US20030175209 Image diagnosis of a brain tumor, renal carcinoma; tumor treatment therapies, immunotherapy
09/18/2003CA2813780A1 Genetic products differentially expressed in tumors and use thereof
09/18/2003CA2478592A1 Genomic screen for epigenetically silenced genes associated with cancer
09/18/2003CA2478510A1 Genomic screen for epigenetically silenced tumor suppressor genes
09/18/2003CA2478479A1 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phagebeta protein, or hydroxyurea
09/18/2003CA2478413A1 Genetic products differentially expressed in tumors and use thereof
09/18/2003CA2478371A1 Compositions and methods for generating an immune response
09/18/2003CA2477780A1 Methods of enhancing immune induction involving mda-7
09/18/2003CA2476767A1 Use of the mal protein as a tumour marker
09/18/2003CA2472782A1 Materials containing multiple layers of vesicles
09/17/2003EP1344829A1 Paramyxovirus vector encoding angiogenesis gene and use thereof
09/17/2003EP1344536A1 Method of regulating the activity of expression product of gene transferred into living body
09/17/2003EP1344064A2 Compositions and methods relating to prostate specific genes and proteins
09/17/2003EP1343913A2 Antisense modulation of src-2 expression
09/17/2003EP1343912A2 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
09/17/2003EP1343901A2 Novel human kinase interacting protein and polynucleotides encoding the same
09/17/2003EP1343900A2 Oxidoreductases
09/17/2003EP1343896A1 Small acid-soluble spore protein and uses thereof
09/17/2003EP1343888A2 Regulation of human chemokine-like receptor
09/17/2003EP1343886A2 Compositions and methods for the therapy and diagnosis of lung cancer
09/17/2003EP1343885A2 Molecules for disease detection and treatment
09/17/2003EP1343884A2 Jfy1 protein induces rapid apoptosis
09/17/2003EP1343822A2 Means for the diagnosis and therapy of ctcl
09/17/2003EP1343818A1 Modified tachykinin receptors
09/17/2003EP1343813A1 Novel compounds
09/17/2003EP1343532A1 Lentiviral vector-mediated gene transfer and uses thereof
09/17/2003EP1343524A1 Vaccine based on a cellular penetration factor from an apicomplexan parasite
09/17/2003EP1343491A2 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy
09/17/2003EP1343367A2 Non-human animal disease models
09/17/2003EP1187627B1 Uses of h-trek-1 polypeptides and polynucleotides encoding them
09/17/2003EP1060242A4 Purified populations of stem cells
09/17/2003CN1443243A 修饰的病毒 Modified viruses
09/17/2003CN1443239A Compositions and methods for therapy and diagnosis of breast cancer
09/17/2003CN1443238A Tumor-specific promoters
09/17/2003CN1443076A Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine
09/17/2003CN1442482A Carrier and method of enhancing gene immune effect and its application in immunology
1 ... 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 ... 870